Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder.

Trial Profile

Comparative Effectiveness of a Second Generation Antipsychotic Mood Stabilizer And a Classic Mood Stabilizer for Bipolar Disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs Lithium (Primary) ; Quetiapine (Primary)
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Acronyms Bipolar CHOICE
  • Most Recent Events

    • 01 Jan 2016 Primary endpoint of Necessary Clinical Adjustments has not been met, according to results published in the Journal of Clinical Psychiatry
    • 01 Jan 2016 Primary endpoint of Clinical Global Impression-Efficacy Index (CGI-EI) has not been met, according to results published in the Journal of Clinical Psychiatry.
    • 01 Jan 2016 Results published in the Journal of Clinical Psychiatry
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top